ESC 365 - Assessing dual pathology in aortic stenosis: Likelihood scores for transthyretin amyloid cardiomyopathy in patients of different aortic stenosis flow groups undergoing TAVI.

ESC Professional Premium Access

Assessing dual pathology in aortic stenosis: Likelihood scores for transthyretin amyloid cardiomyopathy in patients of different aortic stenosis flow groups undergoing TAVI.

Session: New perspectives in cardiology (4) - TAVI and aortic stenosis

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor S. Schwarting (Munich, DE)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Stephanie Schwarting

Ludwig Maximilians University, Munich (Germany)

3 followers

7 more presentations in this session

Discussant - TAVI and aortic stenosis

Residual shear stress following transcatheter aortic valve replacement is associated with rehospitalization for heart failure

Speaker: Doctor S. Kikuchi (Strasbourg, FR)

Safety and efficacy of the Myval transcatheter heart valve: a systematic review and meta-analysis

Speaker: Doctor A. Apostolos (London, GB)

Pre- and post-dilatation practices in transcatheter aortic valve implantation using self-expanding valves: a systematic review and meta-analysis

Speaker: Doctor B. Soh (Galway, IE)

Improved commissural alignment in TAVI: novel approach versus conventional approach with Evolut FX

Speaker: Mr S. Narui (Tokyo, JP)

Access the full session

New perspectives in cardiology (4) - TAVI and aortic stenosis

Speakers: Doctor S. Schwarting, Doctor S. Kikuchi, Doctor A. Apostolos, Doctor B. Soh, Mr S. Narui

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

novartis

Explore sponsored resources